Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.175 USD | +4.79% | +6.91% | +21.73% |
22/05 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
22/05 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Valuation
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Capitalization 1 | 14.12 | 19.98 |
Enterprise Value (EV) 1 | 14.12 | 19.98 |
P/E ratio | - | - |
Yield | - | - |
Capitalization / Revenue | 5.74 x | 1.71 x |
EV / Revenue | 5.74 x | 1.71 x |
EV / EBITDA | - | - |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | - | - |
Nbr of stocks (in thousands) | 5,290 | 6,595 |
Reference price 2 | 2.670 | 3.030 |
Announcement Date | 16/04/24 | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 |
---|---|---|---|
Net sales 1 | - | 2.46 | 11.65 |
EBITDA | - | - | - |
EBIT 1 | - | -6.664 | -0.6272 |
Operating Margin | - | -270.91% | -5.38% |
Earnings before Tax (EBT) | - | - | - |
Net income | -4.78 | - | - |
Net margin | - | - | - |
EPS | -2.770 | - | - |
Free Cash Flow | - | - | - |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 01/06/23 | 16/04/24 | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|
Net sales 1 | 0.5315 | 0.6466 | 2.669 | 3.135 | 3.619 |
EBITDA | - | - | - | - | - |
EBIT 1 | -1.623 | -1.832 | -0.3006 | -0.0055 | 0.2737 |
Operating Margin | -305.42% | -283.33% | -11.26% | -0.18% | 7.56% |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | - | - | - | - | - |
Net margin | - | - | - | - | - |
EPS | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 16/04/24 | 20/05/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 |
---|---|---|---|
Net Debt | - | - | - |
Net Cash position | - | - | - |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | - |
ROE (net income / shareholders' equity) | - | - | - |
ROA (Net income/ Total Assets) | - | - | - |
Assets | - | - | - |
Book Value Per Share | - | - | - |
Cash Flow per Share | - | - | - |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 01/06/23 | 16/04/24 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.73% | 19.98M | |
+75.37% | 12.54B | |
-23.07% | 7.39B | |
+8.08% | 6.62B | |
+14.40% | 5.43B | |
+32.74% | 4.81B | |
-14.85% | 4.8B | |
-25.57% | 3.72B | |
-23.44% | 2.76B | |
+57.67% | 2.4B |
- Stock Market
- Equities
- NRXS Stock
- Financials NeurAxis, Inc.